Hancock Whitney Corp Vanda Pharmaceuticals Inc. Transaction History

Hancock Whitney Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$15.35 - $21.27 $201,944 - $279,828	-13,156 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$15.71 - $21.51 $41,364 - $56,635	-2,633 Reduced 16.68%	13,156 $282,000
Q1 2021 May 14, 2021	BUY	$13.42 - $20.28 $1,959 - $2,960	146 Added 0.93%	15,789 $237,000
Q4 2020 Feb 09, 2021	SELL	$9.77 - $13.81 $53,363 - $75,430	-5,462 Reduced 25.88%	15,643 $205,000
Q3 2020 Nov 05, 2020	BUY	$9.32 - $12.02 $196,698 - $253,682	21,105 New	21,105 $203,000

148

49.6M

49.1K

107K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $298M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.